Black men and prostate cancer
Prostate cancer: the facts
1 in 4 Black men will get prostate cancer. That's double the risk of other men.
As a Black man, you're also more likely to get prostate cancer if:
- you're 45 or over – and your risk gets higher as you get older
- your dad or brother has had prostate cancer.
If you have mixed Black ethnicity you may be at higher risk of prostate cancer than other ethnicities. But we don't know your exact risk because we don't have enough information on prostate cancer in men with mixed Black ethnicity. And we don't know whether it makes a difference if it's you mother or father who is Black.
I’m a Black man over 45. What should I do?
If you’re a Black man, and you’re over 45, speak to your GP about your risk of prostate cancer. We also strongly recommend you speak to them about having a PSA blood test – a simple test that can help diagnose prostate cancer.
There are advantages and disadvantages to having a PSA blood test, so you should talk to your GP or practice nurse about these before deciding whether to have one. You should also tell them if anyone in your family has had prostate cancer or breast cancer.
Need more information? You can also use our Risk information service to speak to a prostate cancer expert and find out more about your risk.
Or you might find it helpful to take our online Risk checker. More than 190,000 Black men have already completed the Risk checker – and it only takes 30 seconds.
I’m a Black man under 45. What should I do?
As a Black man, you can get prostate cancer at a younger age than other men and your risk increases as you get older. It’s not common for men under 45 to get prostate cancer, but it is possible. So if you notice changes in how you wee, or if it becomes painful, it’s important to get it checked by your GP.
We strongly recommend you speak to your GP about your risk of prostate cancer and the PSA blood test from the age of 45. But you can also talk to them now if you’re concerned. They will talk to you about the advantages and disadvantages of the PSA blood test to help you decide if it’s right for you.
I don't have any symptoms. Should I still go to my GP?
Most men with early prostate cancer – cancer that’s contained inside the prostate – don’t have any symptoms.
If the cancer breaks out of the prostate, it's known as locally advanced prostate cancer. If it spreads to other parts of the body, it's known as advanced prostate cancer. At these stages, you might experience other symptoms.
If you do have prostate cancer and it’s found early, there's a better chance that treatment will be able to cure it. But if the cancer has spread there are also treatments to control it and manage any symptoms you might have.
What will happen if I go to my GP?
You can speak to your GP about your increased risk as a Black man and the tests you can have to diagnose prostate cancer. There are a few tests that can find out whether you might have prostate cancer or another prostate problem, such as an enlarged prostate or prostatitis.
It’s normal to feel worried or embarrassed about going to the doctor or having tests. But don’t let that stop you going to talk to your GP. Remember, the tests give your GP the best information about whether you have a problem that needs treating.
Not sure what to say to your GP? We can help with that. To help you with the conversation, print and fill out this simple form and show it to your GP at your appointment.
You can also read more about tests or download our leaflet Prostate cancer and other prostate problems: Information for Black men. Our Risk information service can also help you find out what to expect at a GP appointment.
Are there other Black men I can talk to about prostate cancer?
If you or someone you know has been diagnosed with prostate cancer, you don’t have to navigate this journey alone. We’re here to help.
Our free Black men's One-to-One Peer Support service is like having a friend on the phone who knows exactly what you’re going through. We’ll match you with a trained volunteer who understands what you’re feeling because they’ve been there themselves.
Our trusted volunteers can support you by sharing their own experiences of prostate cancer. You can ask them about making treatment decisions, coping with side effects or how prostate cancer might affect your sex life. And much more.
If you have any questions about prostate cancer or prostate problems and you’d like to speak to a friendly and knowledgeable health professional, our Specialist Nurses are here for you too. You can get in touch by phone, email or live chat.
References and reviewers
Updated: April 2026|To be reviewed: April 2029
- Acute prostatitis - Symptoms, diagnosis and treatment | BMJ Best Practice [Internet]. 2024 [cited 2024 Apr 8]. Available from: https://bestpractice.bmj.com/topics/en-gb/172?q=Prostatitis&c=suggested
- Ali A, Elumalai T, Venkatesulu B, Hekman L, Mistry H, Sachdeva A, et al. Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis. BMJ Oncol. 2024 Apr 3;3(1):e000193. doi:10.1136/bmjonc-2023-000193 PubMed PMID: 39886173; PubMed Central PMCID: PMC11234997.
- Baraban E, Ding CKC, White M, Vohra P, Simko J, Boyle K, et al. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy. Am J Surg Pathol. 2022 Dec;46(12):1650. doi:10.1097/PAS.0000000000001964
- Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, et al. The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study. Eur Urol. 2008 Jan;53(1):99–105. doi:10.1016/j.eururo.2007.02.047
- BMJ. Primary prostate pain syndrome [Internet]. BMJ Best Practice; 2023 [cited 2024 Apr 24]. Available from: https://bestpractice.bmj.com/topics/en-gb/3000324/pdf/3000324/Primary%20prostate%20pain%20syndrome.pdf
- Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Koves B, et al. EAU Guidelines on Urological Infections - [Internet]. 2024 [cited 2024 Sep 9]. Available from: https://uroweb.org/guidelines/urological-infections
- Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. Eur Urol. 2023 Jul 1;84(1):13–21. doi:10.1016/j.eururo.2023.01.022
- Cornford P, Tilki D, van der Bergh RCN, Eberli D, De Meerleer G, De Santis M, et al. EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer. European Association of Urology; 2025.
- Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, et al. EAU Guidelines on Non Neurogenic Male LUTS [Internet]. European Association of Urology; 2025 [cited 2025 Jul 8]. Available from: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2025.pdf
- de Nie I, de Blok CJM, van der Sluis TM, Barbé E, Pigot GLS, Wiepjes CM, et al. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3293–9. doi:10.1210/clinem/dgaa412
- Engeler D, Baranowski AP, Berghmans B, Birch J, Borovicka J. EAU Guidelines on Chronic Pelvic Pain [Internet]. European Association of Urology; 2024 [cited 2024 Apr 24]. Available from: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Chronic-Pelvic-Pain-2024.pdf
- Genetic and genomic testing [Internet]. Available from: https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/
- Genetic tests to check your cancer risk [Internet]. Available from: https://www.nhs.uk/tests-and-treatments/genetic-tests-for-cancer-risk/
- Gong J, Kim DM, Freeman MR, Kim H, Ellis L, Smith B, et al. Genetic and biological drivers of prostate cancer disparities in Black men. Nat Rev Urol. 2024 May;21(5):274–89. doi:10.1038/s41585-023-00828-w
- Harris M. UK NSC opens consultation on draft prostate cancer screening recommendation – UK National Screening Committee [Internet]. 2025 Nov 28 [cited 2025 Dec 1]. Available from: https://nationalscreening.blog.gov.uk/2025/11/28/uk-nsc-opens-consultation-on-draft-prostate-cancer-screening-recommendation/
- Jarvis TR, Chughtai B, Kaplan SA. Bladder Outlet Obstruction and BPH. Curr Bladder Dysfunct Rep. 2014 Dec;9(4):372–8. doi:10.1007/s11884-014-0263-6
- Javaeed A, Ghauri SK, Ibrahim A, Doheim MF. Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review. Oncol Rev. 2020 Apr 30;14(1):449. doi:10.4081/oncol.2020.449 PubMed PMID: 32399138; PubMed Central PMCID: PMC7212205.
- Khan HM, Cheng HH. Germline genetics of prostate cancer. The Prostate. 2022;82(S1):S3–12. doi:10.1002/pros.24340
- Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Sci Rep. 2017 Dec;7(1):7984. doi:10.1038/s41598-017-06628-8
- Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Med. 2015 Dec;13(1). doi:10.1186/s12916-015-0405-5
- Manfredi C, Ditonno F, Franco A, Bologna E, Licari LC, Arcaniolo D, et al. Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges. Curr Oncol Rep. 2023 Nov 1. doi:10.1007/s11912-023-01470-w
- National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: management [Internet]. 2015. Available from: https://www.nice.org.uk/guidance/cg97
- National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management. NICE Guideline 131 [Internet]. 2021. Available from: https://www.nice.org.uk/guidance/ng131/resources/prostate-cancer-diagnosis-and-management-pdf-66141714312133
- National Institute for Health and Care Excellence. Prostatitis (acute): antimicrobial prescribing. NICE guideline 110 [Internet]. 2018 [cited 2019 Jan 3]. Available from: https://www.nice.org.uk/guidance/ng110
- National Institute for Health and Care Excellence. Suspected cancer: recognition and referral [Internet]. 2025. Available from: https://www.nice.org.uk/guidance/ng234
- National Institute for Health and Care Excellence. Urinary tract infection (lower): antimicrobial prescribing [Internet]. 2018. Available from: https://www.nice.org.uk/guidance/ng109
- Nyberg T, Tischkowitz M, Antoniou AC. BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis. Br J Cancer. 2022 Apr 1;126(7):1067–81. doi:10.1038/s41416-021-01675-5
- Office for Health Improvement and Disparities. GOV.UK [Internet]. 2024 [cited 2025 Apr 22]. Advising men without symptoms of prostate disease who ask about the PSA test. Available from: https://www.gov.uk/government/publications/prostate-specific-antigen-testing-explanation-and-implementation/advising-well-men-about-the-psa-test-for-prostate-cancer-information-for-gps
- Office for Health Improvement and Disparities. GOV.UK [Internet]. 2024 [cited 2025 Apr 22]. PSA testing and prostate cancer: advice for men without symptoms of prostate disease. Available from: https://www.gov.uk/government/publications/prostate-specific-antigen-testing-description-in-brief/psa-testing-and-prostate-cancer-advice-for-men-without-symptoms-of-prostate-disease-aged-50-and-over
- Office for Health Improvement and Disparities. Prostate specific antigen testing: advice for well men aged 50 and over [Internet]. GOV.UK; 2022 [cited 2022 Jan 27]. Available from: https://www.gov.uk/government/publications/prostate-specific-antigen-testing-description-in-brief
- Ørsted DD, Bojesen SE. The link between benign prostatic hyperplasia and prostate cancer. Nat Rev Urol. 2012;10(1):49–54. doi:10.1038/nrurol.2012.192
- Perez-Cornago A, Dunneram Y, Watts EL, Key TJ, Travis RC. Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies. BMC Med. 2022 Dec;20(1):143. doi:10.1186/s12916-022-02336-x
- Ramadani FG, Perdana NR, Ringoringo DRL. Body mass index, obesity and risk of prostate cancer: a systematic review and meta-analysis. Cent Eur J Urol. 2024;77(2):176–88. doi:10.5173/ceju.2023.162 PubMed PMID: 39345322; PubMed Central PMCID: PMC11428363.
- Rees J, Abrahams M, Doble A, Cooper A, the Prostatitis Expert Reference Group (PERG). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015 Oct;116(4):509–25. doi:10.1111/bju.13101
- Rivera-Izquierdo M, Pérez De Rojas J, Martínez-Ruiz V, Arrabal-Polo MÁ, Pérez-Gómez B, Jiménez-Moleón JJ. Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):411–21. doi:10.1038/s41391-021-00481-7
- Sellers J, Wagstaff RG, Helo N, de Riese WTW. Quantitative measurements of prostatic zones by MRI and their dependence on prostate size: possible clinical implications in prostate cancer. Ther Adv Urol. 2021 Jan;13:175628722110008. doi:10.1177/17562872211000852
- Shah A, Shah AA, K N, Lobo R. Mechanistic targets for BPH and prostate cancer–a review. Rev Environ Health. 2021 Jun 25;36(2):261–70. doi:10.1515/reveh-2020-0051
- Shoskes DA. The Challenge of Erectile Dysfunction in the Man with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Curr Urol Rep. 2012 May 13;13(4):263–7. doi:10.1007/s11934-012-0254-0
- Frank Chinegwundoh, Consultant Urological Surgeon, Barts Health NHS Trust
- Bunmi Olajide, GP Partner, The College Practice, Rush Green Medical Centre
- Anna Wilson, Urology Nurse Consultant, University Hospitals Plymouth NHS Trust
- our Specialist Nurses
- our volunteers.